Click to view our statement on Accessibility

Suggested Searches

    Popular Searches

    Back
    Events

    Biosimilars: Can They Break Through?

    18 November 2015

    People

    David L. Rosen

    Washington, D.C. 202.672.5430

    Related Insights

    View All Posts
    June 17, 2025 Health Care Law Today

    Oregon’s New Corporate Practice of Medicine Restrictions: Five Takeaways for Digital Health and Telemedicine Companies

    On June 9, 2025, Oregon’s governor signed SB 951 into law, making Oregon one of the most restrictive states in the country with respect…
    June 17, 2025 Foley Viewpoints

    Federal Court Enforces Forum Selection Clause in Dealer Dispute with Equipment Manufacturer

    A federal district court recently enforced a forum selection clause in National Equipment Dealers, LLC v. IROCK Crushers LLC,…
    June 17, 2025 Tariff & International Trade Resource

    What Every Multinational Company Should Know About … Mitigating Risks Posed by the New Trump Administration Focus on Drug Cartels and TCOs

    The Trump Administration’s crackdown on cartels and transnational criminal organizations operating abroad and in the United States is a significant Department of Justice priority.